12 Health Care Stocks Moving In Thursday's After-Market Sessionbenzinga_article·Oct 15, 2026 at 09:05 PMADXN-1.97%AIDX+1.96%
12 Health Care Stocks Moving In Thursday's Pre-Market Sessionbenzinga_article·Oct 15, 2026 at 12:12 PMADXN-1.97%ALVR0.00%
Addex Therapeutics appoints Jean-Philippe Rocher head of pharmaceutical developmentPUBT·Oct 2, 2026 at 05:00 AMADXN-1.97%
Addex Therapeutics Earnings Call Highlights Pipeline UpsideTip Ranks·Sep 29, 2026 at 12:13 AMADXN-1.97%
12 Health Care Stocks Moving In Monday's Pre-Market Sessionbenzinga_article·Sep 28, 2026 at 12:05 PMAPUS-4.69%ARAY-3.52%
Addex Therapeutics Reports 2026 Half-Year Results and Provides Corporate UpdateGlobeNewswire·Sep 28, 2026 at 05:00 AMADXN-1.97%INDV+0.06%
Earnings Scheduled For September 28, 2026benzinga_article·Sep 28, 2026 at 11:11 AMADXN-1.97%IDT-1.80%
Addex management commentary: H1 2026 net loss holds near CHF 3.5 million as Neurosterix share-of-loss offsets lower R&D spendPUBT·Sep 28, 2026 at 11:07 AMADXN-1.97%
Addex H1 FY26 net loss widens 4.29% to CHF 3.46 million; operating loss narrows 15.98% to CHF 1.13 millionPUBT·Sep 28, 2026 at 05:00 AMADXN-1.97%
APE: Raised USD 2.8M, regained GABAB PAM rights, and reported CHF 3.5M net loss for H1 2026Quartr·Sep 28, 2026 at 05:26 AMADXN-1.97%
